TY  - ADVS
AU  - Stingl,Julia
TI  - Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism: Part II. Internal medicine 
T2  - Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance,
PY  - 2016///
CY  - London
PB  - Henry Stewart Talks
KW  - Cytochrome P-450
KW  - Drugs
KW  - Metabolism
KW  - Pharmacogenetics
KW  - Cytochrome P-450 Enzyme System
KW  - Enzymes
KW  - pharmacokinetics
KW  - Inactivation, Metabolic
KW  - Pharmaceutical Preparations
KW  - metabolism
KW  - methods
KW  - Polymorphism, Genetic
KW  - Risk Assessment
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Updated version of a talk first published in 2007; Contents: Genetic variability in pharmacokinetics -- Polymorphic drug-metabolizing enzymes (Cytochrome P450) -- Implementation of pharmacogenetics in drug therapy -- Risks and benefits of being a poor metabolizer -- Limitations of genetics-based dose adjustments -- Future clinical study directions in pharmacogenetics; Access restricted to subscribers
UR  - https://hstalks.com/bs/698/
UR  - https://hstalks.com/bs/p/16/
ER  -